X. Y. Cai, Dendritic cell infiltration and prognosis of human hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, vol.4, issue.3, 2006.
DOI : 10.1007/s00432-006-0075-y

A. Troy, P. Davidson, C. Atkinson, H. , and D. , PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER, The Journal of Urology, vol.160, issue.1, pp.214-219, 1998.
DOI : 10.1016/S0022-5347(01)63093-3

F. O. Nestle, G. Burg, J. Fah, T. Wrone-smith, and B. J. Nickoloff, Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells, Am. J. Pathol, vol.150, pp.641-651, 1997.

A. Bergeron, F. El-hage, M. Kambouchner, D. Lecossier, and A. Tazi, Characterisation of dendritic cell subsets in lung cancer micro-environments, European Respiratory Journal, vol.28, issue.6, pp.1170-1177, 2006.
DOI : 10.1183/09031936.06.00114205

G. Gerlini, Metastatic Melanoma Secreted IL-10 Down-Regulates CD1 Molecules on Dendritic Cells in Metastatic Tumor Lesions, The American Journal of Pathology, vol.165, issue.6, pp.1853-1863, 2004.
DOI : 10.1016/S0002-9440(10)63238-5

I. Treilleux, Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer, Clinical Cancer Research, vol.10, issue.22, pp.7466-7474, 2004.
DOI : 10.1158/1078-0432.CCR-04-0684

M. Movassagh, Selective Accumulation of Mature DC-Lamp+ Dendritic Cells in Tumor Sites Is Associated with Efficient T-Cell-Mediated Antitumor Response and Control of Metastatic Dissemination in Melanoma, Cancer Research, vol.64, issue.6, pp.2192-2198, 2004.
DOI : 10.1158/0008-5472.CAN-03-2969

P. Chaux, A. Hammann, F. Martin, and M. Martin, Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation, European Journal of Immunology, vol.2, issue.10, pp.2517-2525, 1993.
DOI : 10.1002/eji.1830231021

P. Chaux, N. Favre, M. Martin, M. , and F. , Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats, International Journal of Cancer, vol.105, issue.4, pp.619-624, 1997.
DOI : 10.1002/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.0.CO;2-6

A. P. Vicari, Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti???Interleukin 10 Receptor Antibody, The Journal of Experimental Medicine, vol.194, issue.4, pp.541-549, 2002.
DOI : 10.4049/jimmunol.167.9.4878

C. Guiducci, A. P. Vicari, S. Sangaletti, G. Trinchieri, and M. P. Colombo, Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection, Cancer Res, vol.65, pp.3437-3446, 2005.

O. Preynat-seauve, Tumor-Infiltrating Dendritic Cells Are Potent Antigen-Presenting Cells Able to Activate T Cells and Mediate Tumor Rejection, The Journal of Immunology, vol.176, issue.1, pp.61-67, 2006.
DOI : 10.4049/jimmunol.176.1.61

D. Gabrilovich, Mechanisms and functional significance of tumour-induced dendritic-cell defects, Nature Reviews Immunology, vol.172, issue.12, pp.941-952, 2004.
DOI : 10.1073/pnas.172384399

D. Bell, In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, whereas Mature Dendritic Cells Are Located in Peritumoral Areas, Journal of Experimental Medicine, vol.190, issue.10, pp.1417-1426, 1999.
DOI : 10.1084/jem.190.10.1417

I. Perrot, Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage, The Journal of Immunology, vol.178, issue.5, pp.2763-2769, 2007.
DOI : 10.4049/jimmunol.178.5.2763

F. Ghiringhelli, regulatory T cell proliferation, The Journal of Experimental Medicine, vol.71, issue.7, pp.919-929, 2005.
DOI : 10.1084/jem.191.7.1187
URL : https://hal.archives-ouvertes.fr/inserm-00857882

T. J. Curiel, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nature Medicine, vol.165, issue.9, pp.942-949, 2004.
DOI : 10.1016/S0022-1759(01)00359-3

F. Ghiringhelli, CD4+CD25+ regulatory T???cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, European Journal of Immunology, vol.34, issue.2, pp.336-344, 2004.
DOI : 10.1002/eji.200324181

M. L. Chen, Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-?? signals in vivo, Proceedings of the National Academy of Sciences, vol.102, issue.2, pp.419-424, 2005.
DOI : 10.1073/pnas.0408197102

F. Ghiringhelli, regulatory T cells inhibit natural killer cell functions in a transforming growth factor????????dependent manner, The Journal of Experimental Medicine, vol.9, issue.8, pp.1075-1085, 2005.
DOI : 10.4049/jimmunol.172.10.5957
URL : https://hal.archives-ouvertes.fr/pasteur-00020140

S. Tsuji, Maturation of Human Dendritic Cells by Cell Wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: Involvement of Toll-Like Receptors, Infection and Immunity, vol.68, issue.12, pp.6883-6890, 2000.
DOI : 10.1128/IAI.68.12.6883-6890.2000

T. Akazawa, Adjuvant-Mediated Tumor Regression and Tumor-Specific Cytotoxic Response Are Impaired in MyD88-Deficient Mice, Cancer Research, vol.64, issue.2, pp.757-764, 2004.
DOI : 10.1158/0008-5472.CAN-03-1518

J. Taieb, A novel dendritic cell subset involved in tumor immunosurveillance, Nature Medicine, vol.167, issue.2, pp.214-219, 2006.
DOI : 10.1038/nm1356
URL : https://hal.archives-ouvertes.fr/hal-00094696

C. W. Chan, Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity, Nature Medicine, vol.12, issue.2, pp.207-213, 2006.
DOI : 10.1038/nm1352

K. A. Heldwein, TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG, Journal of Leukocyte Biology, vol.74, issue.2, pp.277-286, 2003.
DOI : 10.1189/jlb.0103026

F. Von-meyenn, Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Gu??rin by Flt3-ligand generated dendritic cells, Immunobiology, vol.211, issue.6-8, pp.557-565, 2006.
DOI : 10.1016/j.imbio.2006.05.004

F. Ghiringhelli, Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients, Cancer Immunology, Immunotherapy, vol.95, issue.5, pp.641-648, 2007.
DOI : 10.1007/s00262-006-0225-8

M. E. Lutsiak, Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide, Blood, vol.105, issue.7, pp.2862-2868, 2005.
DOI : 10.1182/blood-2004-06-2410

D. L. Lamm, Efficacy and Safety of Bacille Calmette-Guerin Immunotherapy in Superficial Bladder Cancer, Clinical Infectious Diseases, vol.31, issue.Supplement 3, pp.86-90, 2000.
DOI : 10.1086/314064

J. B. Vermorken, Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial, The Lancet, vol.353, issue.9150, pp.345-350, 1999.
DOI : 10.1016/S0140-6736(98)07186-4

I. Fricke, Mycobacteria Induce IFN-?? Production in Human Dendritic Cells via Triggering of TLR2, The Journal of Immunology, vol.176, issue.9, pp.5173-5182, 2006.
DOI : 10.4049/jimmunol.176.9.5173

T. J. Kemp, Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L, Blood, vol.106, issue.10, pp.3474-3482, 2005.
DOI : 10.1182/blood-2005-03-1327

A. T. Ludwig, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: A Novel Mechanism for Bacillus Calmette-Guerin-Induced Antitumor Activity, Cancer Research, vol.64, issue.10, pp.3386-3390, 2004.
DOI : 10.1158/0008-5472.CAN-04-0374

M. Korthals, Monocyte derived dendritic cells generated by IFN-?? acquire mature dendritic and natural killer cell properties as shown by gene expression analysis, Journal of Translational Medicine, vol.5, issue.1, p.46, 2007.
DOI : 10.1186/1479-5876-5-46

G. E. Diehl, TRAIL-R as a Negative Regulator of Innate Immune Cell Responses, Immunity, vol.21, issue.6, pp.877-889, 2004.
DOI : 10.1016/j.immuni.2004.11.008

J. Taieb, Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines, The Journal of Immunology, vol.176, issue.5, pp.2722-2729, 2006.
DOI : 10.4049/jimmunol.176.5.2722

M. J. Turk, Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells, The Journal of Experimental Medicine, vol.59, issue.6, pp.771-782, 2004.
DOI : 10.1038/nature01152

S. Hori, T. Nomura, and S. Sakaguchi, Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-1061, 2003.
DOI : 10.1126/science.1079490

D. J. Kasprowicz, Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death, European Journal of Immunology, vol.23, issue.12, pp.3424-3432, 2005.
DOI : 10.1002/eji.200526339

G. Schiavoni, Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, Blood, vol.95, pp.2024-2030, 2000.

F. Ghiringhelli, C. Menard, F. Martin, and L. Zitvogel, The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression, Immunological Reviews, vol.170, issue.1, pp.229-238, 2006.
DOI : 10.1016/S0092-8674(00)81460-9

T. J. Curiel, Tregs and rethinking cancer immunotherapy, Journal of Clinical Investigation, vol.117, issue.5, pp.1167-1174, 2007.
DOI : 10.1172/JCI31202

J. C. Lee, K. M. Lee, D. W. Kim, and D. S. Heo, Elevated TGF-??1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients, The Journal of Immunology, vol.172, issue.12, pp.7335-7340, 2004.
DOI : 10.4049/jimmunol.172.12.7335

E. Ullrich, Trans-Presentation of IL-15 Dictates IFN-Producing Killer Dendritic Cells Effector Functions, The Journal of Immunology, vol.180, issue.12, pp.7887-7897, 2008.
DOI : 10.4049/jimmunol.180.12.7887
URL : https://hal.archives-ouvertes.fr/hal-00363902

M. J. Smyth, CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer, The Journal of Immunology, vol.176, issue.3, pp.1582-1587, 2006.
DOI : 10.4049/jimmunol.176.3.1582

A. K. Wesa and W. J. Storkus, Killer dendritic cells: mechanisms of action and therapeutic implications for cancer, Cell Death and Differentiation, vol.168, issue.1, pp.51-57, 2008.
DOI : 10.1146/ANNUREV.IMMUNOL.18.1.767

E. Ullrich, N. Chaput, and L. Zitvogel, Killer Dendritic Cells and their Potential Role in Immunotherapy, Hormone and Metabolic Research, vol.40, issue.2, pp.1-7, 2008.
DOI : 10.1055/s-2007-1022554

A. Nicolas, Dendritic Cells Trigger Tumor Cell Death by a Nitric Oxide-Dependent Mechanism, The Journal of Immunology, vol.179, issue.2, 2007.
DOI : 10.4049/jimmunol.179.2.812

J. Shi, Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells, Cancer Science, vol.163, issue.2, pp.127-133, 2005.
DOI : 10.1084/jem.177.2.295

P. P. Manna and T. Mohanakumar, Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro, J. Leukoc. Biol, vol.72, pp.312-320, 2002.

A. L. Blasius, W. Barchet, M. Cella, and M. Colonna, cells identify them as a subset of NK cells, The Journal of Experimental Medicine, vol.147, issue.11, pp.2561-2568, 2007.
DOI : 10.1073/pnas.0403744101

C. A. Vosshenrich, interferon-producing killer dendritic cells are activated natural killer cells, The Journal of Experimental Medicine, vol.154, issue.11, pp.2569-2578, 2007.
DOI : 10.1038/76917

I. Caminschi, Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells, The Journal of Experimental Medicine, vol.162, issue.11, pp.2579-2590, 2007.
DOI : 10.1093/intimm/dxl011

A. Caignard, M. S. Martin, M. F. Michel, M. , and F. , Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host, International Journal of Cancer, vol.45, issue.2, pp.273-279, 1985.
DOI : 10.1002/ijc.2910360221

N. Kayagaki, Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells, J. Immunol, vol.163, pp.1906-1913, 1999.

F. J. Barrat, Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus, The Journal of Experimental Medicine, vol.32, issue.8, pp.1131-1139, 2005.
DOI : 10.4049/jimmunol.171.6.3296

B. Bonnotte, Identification of tumorinfiltrating macrophages as the killers of tumor cells after immunization in a rat model system, 2001.

N. A. Fanger, C. R. Maliszewski, K. Schooley, G. , and T. S. , Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor???Related Apoptosis-Inducing Ligand (Trail), The Journal of Experimental Medicine, vol.158, issue.8, pp.1155-1164, 1999.
DOI : 10.1126/science.1352913